arginine has been researched along with acetazolamide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Campbell, AD; Huf, EG; Pinschmidt, MW | 1 |
| Coltau, M; Puscas, I | 1 |
| Bonilla-Felix, M; Vehaskari, VM; Villegas-Medina, O | 1 |
| Bakker, WH; Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Rolleman, EJ; Visser, TJ | 1 |
| Dallinger, S; Eichler, HG; Findl, O; Kiss, B; Rainer, G; Schmetterer, L | 1 |
| SCHENKER, S; WARREN, KS | 1 |
| Hur, JK; Kim, JB; Lee, KY | 1 |
| Bauersachs, J; Becker, T; Beckmann, B; Chobanyan, K; Gutzki, FM; Mitschke, A; Pham, VV; Stichtenoth, DO; Thum, T; Tsikas, D | 1 |
| Cannon, SC; Mi, W; Wu, F | 1 |
1 review(s) available for arginine and acetazolamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and acetazolamide
| Article | Year |
|---|---|
Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide.
Topics: Acetazolamide; Adult; Arginine; Blood Vessels; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Eye; Humans; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1999 |
12 other study(ies) available for arginine and acetazolamide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Role of Na+ and anions in the triple response of isolated frog skin to norepinephrine.
Topics: Acetazolamide; Animals; Anura; Arginine; Bicarbonates; Chlorides; Choline; Epithelium; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Membrane Potentials; Norepinephrine; Ouabain; Potentiometry; Propranolol; Rana pipiens; Skin; Skin Physiological Phenomena; Sodium; Sulfates; Time Factors | 1973 |
Inhibition of carbonic anhydrase by nitric oxide.
Topics: Acetazolamide; Animals; Arginine; Carbonic Anhydrase Inhibitors; Cattle; Enzyme Activation; Enzyme Inhibitors; Erythrocytes; Humans; In Vitro Techniques; Kinetics; Male; Nitric Oxide; omega-N-Methylarginine; Parietal Cells, Gastric; Rabbits | 1995 |
Renal acidification in children with idiopathic hypercalciuria.
Topics: Acetazolamide; Acidosis, Renal Tubular; Adolescent; Arginine; Calcium; Child; Child, Preschool; Female; Furosemide; Humans; Hydrogen-Ion Concentration; Male; Oxygen; Urine | 1994 |
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
Topics: Acetazolamide; Animals; Arginine; Cystine; Enzyme Inhibitors; Heptanoates; Kidney; Lysine; Male; Maleates; Octreotide; Pentetic Acid; Radionuclide Imaging; Rats; Rats, Wistar; Sensitivity and Specificity; Tissue Distribution | 1996 |
DRUGS RELATED TO THE EXACERBATION OR AMELIORATION OF HEPATIC COMA AND THEIR EFFECTS ON AMMONIA TOXICITY.
Topics: Acetazolamide; Ammonia; Ammonium Chloride; Arginine; Chlorothiazide; Cortisone; Formaldehyde; Glutamates; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Iproniazid; Mice; Morphine; Paraldehyde; Pentobarbital; Phenobarbital; Research; Toxicology; Tryptophan | 1963 |
A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).
Topics: Acetazolamide; Adolescent; Arginine; Calcium Channels; Calcium Channels, L-Type; Codon; Exons; Family Health; Female; Glycine; Humans; Hypokalemia; Hypokalemic Periodic Paralysis; Korea; Male; Muscle, Skeletal; Mutation; Pedigree; Protein Structure, Tertiary; Sequence Analysis, DNA; Spironolactone | 2005 |
Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease
Topics: Acetazolamide; Adult; Arginine; Benzamides; Circadian Rhythm; Coronary Artery Disease; Dimethylamines; Diuretics; Female; Gas Chromatography-Mass Spectrometry; Health; Humans; Liver Diseases; Male; Middle Aged; Quality Control; Time Factors; Urinalysis | 2007 |
Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
Topics: Acetazolamide; Animals; Arginine; Bumetanide; Calcium Channels, L-Type; Carbonic Anhydrase Inhibitors; Disease Models, Animal; Evoked Potentials, Motor; Furosemide; Glucose; Histidine; Hypokalemic Periodic Paralysis; In Vitro Techniques; Isometric Contraction; Male; Mice; Mice, Transgenic; Muscle, Skeletal; Mutation; Sodium Potassium Chloride Symporter Inhibitors | 2013 |